FDA NDC Directory · JSON-LD · Markdown

haloperidol decanoate

NDC 25021-831 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerSagent Pharmaceuticals
Marketing categoryAbbreviated NDA (generic) · App ANDA205241
Dosage form / routeINJECTION, SOLUTION · INTRAMUSCULAR
Active ingredientsHALOPERIDOL DECANOATE (50 mg/mL)
Marketing started20171115
Package count1

External sources

Source: openFDA. Public-domain (CC0).